Skip to content
20-F

Annual Report (Foreign)

Medifocus Inc.

0001511164-18-000454

← back to feed
Filed
Jul 31, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2018 · Mar 31, 2018 184.98M sh
Cash And Equivalents FY 2018 · Mar 31, 2017 $70.29K
Cash And Equivalents FY 2018 · Mar 31, 2016 $113.95K
Cash And Equivalents FY 2018 · Mar 31, 2015 $1.31M
Current Liabilities FY 2018 · Mar 31, 2017 $11.41M
Total Liabilities FY 2018 · Mar 31, 2017 $11.54M
Current Assets FY 2018 · Mar 31, 2017 $1.26M
Total Assets FY 2018 · Mar 31, 2017 $3.14M
Operating Cash Flow FY 2018 · Mar 31, 2016 −$1.94M
Sga Expense FY 2018 · Mar 31, 2016 $2.73M
Rd Expense FY 2018 · Mar 31, 2016 $626.29K
Net Income FY 2018 · Mar 31, 2016 −$4.96M
Gross Profit FY 2018 · Mar 31, 2016 $1.28M
Cost Of Revenue FY 2018 · Mar 31, 2016 $3.26M